ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 178 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $17,258,000 | +5.6% | 375,000 | 0.0% | 0.62% | -0.6% |
| Q2 2018 | $16,350,000 | +10.4% | 375,000 | 0.0% | 0.63% | -0.5% |
| Q1 2018 | $14,813,000 | +102.8% | 375,000 | +74.4% | 0.63% | +90.9% |
| Q4 2017 | $7,304,000 | +33.2% | 215,000 | 0.0% | 0.33% | +30.8% |
| Q3 2017 | $5,483,000 | – | 215,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |